DOMILEX

Serial Number 87882093
Registration 5789144
700

Registration Progress

Application Filed
Apr 18, 2018
Under Examination
Nov 27, 2018
Approved for Publication
Oct 2, 2018
Published for Opposition
Oct 2, 2018
Registered
Jun 25, 2019

Attorney Assistance

Section 8 (6-Year) Declaration Due (Based on registration date 2019-06-25) (Grace Period Filing)
Due: Dec 25, 2025 Grace Period - 143 days
Original deadline was Jun 25, 2025 (overdue)

Trademark Image

DOMILEX

Basic Information

Serial Number
87882093
Registration Number
5789144
Filing Date
April 18, 2018
Registration Date
June 25, 2019
Published for Opposition
October 2, 2018
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 25, 2019
Registration
Registered
Classes
005

Rights Holder

EnBio-Life Biotechnology & Medical Co., Ltd

03
Address
5F No 1027 Sec 3 Wenxin Rd Beitun Dist
Taichung City 406
TW

Ownership History

EnBio-Life Biotechnology & Medical Co., Ltd

Original Applicant
03
Taichung City 406 TW

EnBio-Life Biotechnology & Medical Co., Ltd

Owner at Publication
03
Taichung City 406 TW

EnBio-Life Biotechnology & Medical Co., Ltd

Original Registrant
03
Taichung City 406 TW

Legal Representation

Attorney
Raymond R. Moser, Jr.

USPTO Deadlines

Next Deadline
In Grace Period
Section 8 (6-Year) Declaration Due (Based on registration date 2019-06-25)
Due Date
June 25, 2025
Grace Period Ends
December 25, 2025
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

23 events
Date Code Type Description Documents
Jun 25, 2024 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Jun 25, 2019 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
May 18, 2019 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
May 17, 2019 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Apr 26, 2019 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Apr 26, 2019 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Apr 15, 2019 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Apr 15, 2019 IUAF S USE AMENDMENT FILED Loading...
Nov 27, 2018 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 2, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 2, 2018 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 12, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 23, 2018 ALIE A ASSIGNED TO LIE Loading...
Aug 14, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 11, 2018 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 10, 2018 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 10, 2018 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 9, 2018 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 9, 2018 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 9, 2018 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 8, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 26, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 21, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Biological preparations for the treatment of immune system related disease and disorders; Food supplements, namely, anti-oxidants; Mineral nutritional supplements; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical products for treating respiratory diseases and asthma; Protein dietary supplements
First Use Anywhere: Jan 1, 2007
First Use in Commerce: Apr 12, 2019

Classification

International Classes
005